Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Katsuo, Chihiro, Kubota, Kensuke, Tanaka, Katsushi, kurita, Yusuke, Nakajima, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2023
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518534/
https://www.ncbi.nlm.nih.gov/pubmed/37661419
http://dx.doi.org/10.2169/internalmedicine.E002-23
_version_ 1785109535518621696
author Katsuo, Chihiro
Kubota, Kensuke
Tanaka, Katsushi
kurita, Yusuke
Nakajima, Atsushi
author_facet Katsuo, Chihiro
Kubota, Kensuke
Tanaka, Katsushi
kurita, Yusuke
Nakajima, Atsushi
author_sort Katsuo, Chihiro
collection PubMed
description
format Online
Article
Text
id pubmed-10518534
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-105185342023-09-26 Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan Katsuo, Chihiro Kubota, Kensuke Tanaka, Katsushi kurita, Yusuke Nakajima, Atsushi Intern Med Erratum The Japanese Society of Internal Medicine 2023-09-01 /pmc/articles/PMC10518534/ /pubmed/37661419 http://dx.doi.org/10.2169/internalmedicine.E002-23 Text en Copyright © 2023 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Erratum
Katsuo, Chihiro
Kubota, Kensuke
Tanaka, Katsushi
kurita, Yusuke
Nakajima, Atsushi
Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan
title Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan
title_full Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan
title_fullStr Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan
title_full_unstemmed Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan
title_short Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan
title_sort combined regn-cov2 antibody therapy immediately prevented a patient with refractory type 1 autoimmune pancreatitis from contracting sars-cov-2 during the sixth wave in japan
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518534/
https://www.ncbi.nlm.nih.gov/pubmed/37661419
http://dx.doi.org/10.2169/internalmedicine.E002-23
work_keys_str_mv AT katsuochihiro combinedregncov2antibodytherapyimmediatelypreventedapatientwithrefractorytype1autoimmunepancreatitisfromcontractingsarscov2duringthesixthwaveinjapan
AT kubotakensuke combinedregncov2antibodytherapyimmediatelypreventedapatientwithrefractorytype1autoimmunepancreatitisfromcontractingsarscov2duringthesixthwaveinjapan
AT tanakakatsushi combinedregncov2antibodytherapyimmediatelypreventedapatientwithrefractorytype1autoimmunepancreatitisfromcontractingsarscov2duringthesixthwaveinjapan
AT kuritayusuke combinedregncov2antibodytherapyimmediatelypreventedapatientwithrefractorytype1autoimmunepancreatitisfromcontractingsarscov2duringthesixthwaveinjapan
AT nakajimaatsushi combinedregncov2antibodytherapyimmediatelypreventedapatientwithrefractorytype1autoimmunepancreatitisfromcontractingsarscov2duringthesixthwaveinjapan

Ejemplares similares